Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. There were three Cohorts, with 12 patients in each cohort. www.igcinc.us , www.igcpharma.com.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

Cannabis Law Report

JUNE 7, 2021

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. As previously disclosed, IGC submitted IGC-AD1 to the U.S.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

CannaMD

NOVEMBER 4, 2020

According to a recent study published in the Journal of Headache Pain , across 2,032 patients and 21 illnesses, headache was a symptom treated with cannabis in 24.9% (505) of cases, while 88% (445) of headache patients treated probable migraines with cannabis. 30 percent of migraine patients in the U.S. The results?

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. Anonymized data also helps scientists better understand the cannabis plant and what products and chemical profiles are most effective for treating different conditions and symptoms.

Data 100

Data Research and Development Patients Strains 100

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition. Patients can also access CBD products without a prescription through local pharmacies.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking. CBD VS. THC.

THC 111

THC CBD Data Cannabinoids 111

The Joint Blog

MARCH 2, 2020

According to a new study published in the journal Trauma Surgery & Acute Care , trauma patients who are administered THC capsules consume fewer opioids than do similarly matched control subjects. 66 patients participated in the study: Half received THC, and the other half did not. hours from admission minus 0–48?hours

Patients 47

Patients THC Consumption Data 47

SpeedWeed

APRIL 10, 2021

Chronic pain patients who used cannabis saw sustained improvement in their condition over time, according to the results of a recently released study. The data revealed a sustained improvement in the participants’ symptoms. Different Effects Noted For THC, CBD. An abstract of the research, “No pain, all gain?

Chronic Pain 52

Chronic Pain Patients Treatment Data 52

Cannabis Law Report

SEPTEMBER 12, 2022

The Medical Cannabis Advisory Board declined to enact a proposed cap on THC in medical cannabis products. THC – short for tetrahydrocannabinol – is the main psychoactive component in cannabis. Many speakers said 10 percent THC would make medical marijuana ineffective for many patients and only create more problems. “I

THC 52

THC Data Conditions Cannabis 52

Cannabis Law Report

MARCH 22, 2020

Mugglehead reports… Previous tests with THC in mice with influenza showed an increase in viral loads. A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. World Health Organization (WHO).

THC 59

THC Clinical Trials Data Consumption 59

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC.

Epilepsy 66

Epilepsy Pharmaceutical Patients Sleep 66

SpeedWeed

MARCH 6, 2021

Proposals to cap the amount of THC in cannabis flower and concentrates have been gaining traction in a number of state legislatures, and earlier this week the idea reached the federal level. Most cannabis flower in America’s legal regulated markets ranges between 18% and 23% THC. Forcing patients to purchase more.

THC 52

THC Patients Law Chronic Pain 52

MedicalJane

JUNE 12, 2020

Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. The control group consisted of 271 adult patients who were considering cannabis use, and 197 adult caregivers who were considering it for a dependent child or adult patient.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Project CBD

MARCH 21, 2023

She was upset with herself for being so careless and concerned that the condition would persist. For many other people of all ages, tinnitus is indeed a chronic condition that has nothing to do with loud ‘80s cover bands in small clubs. And it’s not just ringing.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Veriheal

JULY 5, 2021

Cannabis is brimming with hundreds of active cannabinoids, but just two have really managed to steal the limelight – THC (tetrahydrocannabinol) and CBD (cannabidiol). sales last year—a recent study has confirmed that these cannabinoid receptor-binding molecules offer different levels of symptomatic relief for nausea patients. .

THC 52

THC CBD Treatment Cannabinoids 52

Veriheal

NOVEMBER 18, 2022

According to their announcement , the boxing legends have teamed up to pay homage to their infamous moment with a line of THC and Delta-8 edibles called “Holy Ears.” Texas’ medical cannabis program is in the midst of a massive spike in patient registrations. Will you be buying some Holy Ear edibles? Let us know in the comments!

Edibles 97

Edibles Hemp Epilepsy Programs 97

NORML

MARCH 20, 2019

A widely reported study appearing today in the British journal The Lancet alleges that an estimated 30 to 50 percent of psychosis cases in Europe are due to cannabis exposure, and that exposure to elevated levels of THC increases this risk. But it is not evidence that marijuana in any way causes the condition.

THC 280

THC Data Cannabis Events 280

Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. of patients experience pain after curative treatment, while 66.4% of patients with advanced or metastatic cancer suffer from pain. Interestingly, 72.5%

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

MAY 19, 2022

Food & Drug Administration (FDA) recently issued Warning Letters to five companies selling products containing delta-8 tetrahydrocannabinol (delta-8 THC) and cannabidiol (CBD). The agency also particularly noted its serious concerns with the potential health effects of delta-8 THC products. Background.

THC 52

THC CBD Food Pets 52

Veriheal

JANUARY 26, 2023

Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. However, pharmaceutical medications can have side effects, and they may take longer to work for many patients.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. Orphan Drug Designation?

DEA 66

DEA Clinical Trials THC Research and Development 66

Project CBD

JANUARY 24, 2019

Published in Nature , the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD -rich oil derived from cannabis (30% CBD , 1-2% THC ). Previous research has found that THC may be effective for some cases that do not respond well to Ritalin. .

Research and Development 252

Research and Development Chronic Pain Cannabinoids Treatment 252

The Cannigma

NOVEMBER 11, 2021

Amid speculation on whether cannabidiol (CBD) can influence the intoxicating effects of d9-tetrahydrocannabinol (THC), a new study supports this idea, along with another unexpected and interesting finding related to a serious mental health disorder. CBD alters the subjective effects of THC. mg total cannabinoids.

CBD 139

CBD Research and Development THC Environment 139

The Joint Blog

APRIL 17, 2020

According to a new study in the Journal of Clinic Medicine , the use of Tetrahydrocannabinol (THC) could have adverse drug effects when combined with other medications due to drug-drug interactions. Its psychoactive ingredient, THC, has made cannabis a highly used recreational drug for millennia. Cannabis Sativa, a.k.a

Events 48

Events THC Chronic Pain Sleep 48

Veriheal

AUGUST 15, 2022

The condition may also occur as a result of poor lifestyle habits, chronic disease, and depression. Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. Minor Cannabinoids vs. CBD and THC. Promising News for Endless Patients. The Releaf App’s Role in the Fatigue Study.

Treatment 96

Treatment Research and Development Sativa Cannabinoids 96

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. Related story Can CBD Help Your Condition? CBD for hypertension. Preclinical promise.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Puff Puff Post

MARCH 2, 2020

Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. Web Site: [link].

Extraction 52

Extraction THC Chronic Pain Cultivation 52

Veriheal

MAY 18, 2023

Chronic pain —a condition that affects 50.2 annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. The list is designed to help patients determine whether or not they are a good candidate for (and would benefit from) a medical marijuana card.

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

Cannabis Law Report

JULY 29, 2021

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union. Initial shipment of THC extracts into the European Union. About Avicanna.

Extraction 98

Extraction Supply Chain THC Research and Development 98

PrestoDoctor

SEPTEMBER 6, 2023

Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain. It has been a go-to option for healthcare professionals seeking to manage pain effectively for their patients.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Veriheal

NOVEMBER 22, 2021

Headset , a leading cannabis data and market intelligence platform, recently conducted an audit of cannabis sales data around the United States—and the discoveries were interesting. To understand why medical patients might be purchasing more cannabis than recreational users, we have to look at buying behaviors.

Recreational 98

Recreational Data Dispensary Cannabis 98

FloridaMarijuana.net

JUNE 27, 2018

The study’s data showed that “Cannabis significantly reduced ratings of depression, anxiety, and stress.” Furthermore, researchers from the Washington State University found that cannabis with a low concentration of THC and high CBD concentration had the best results in reducing perceived symptoms of depression.

Treatment 100

Treatment Marijuana Conditions Data 100

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs. THC VS. CBD.

Data 89

Data Chronic Pain Sleep Patients 89

Project CBD

AUGUST 6, 2019

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. Related story Can CBD Help Your Condition? CBD for hypertension. Preclinical promise.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

The Cannigma

OCTOBER 21, 2021

Still, many patients report that cannabis helps them to feel more in control of their symptoms, leading to important questions. Attention deficit hyperactivity disorder, or ADHD, is a condition characterized by behavioral symptoms such as inattentiveness, hyperactivity, impulsiveness. Can cannabis help with ADHD? What is ADHD?

Blood Pressure 137

Blood Pressure Treatment Patients Cannabis 137